Precision Medicine Online
banner
precmedonline.bsky.social
Precision Medicine Online
@precmedonline.bsky.social
Precision Medicine Online is an online newsroom that tracks the industry players and healthcare systems driving the adoption of precision medicine. Read the latest news at www.precisionmedicineonline.com.
Reposted by Precision Medicine Online
I recently wrote about cancer screening and surveillance for transgender patients, particularly those with hereditary cancer risk gene variants. www.precisionmedicineonline.com/precision-on...
Transgender Patients With Hereditary Cancer Risk Variants Benefit From Individualized Approach
Doctors are using limited guidance on screening and treatment approaches for transgender patients predisposed to cancer while considering patient preferences and treatment goals.
www.precisionmedicineonline.com
November 8, 2024 at 5:22 PM
Reposted by Precision Medicine Online
"This case is concerning because the neurologist not only ordered the wrong test but didn't recognize the error even after seeing a report...entirely unrelated to ataxia." The latest in GenomeWeb's Genetic Testing Challenges series with @ellenmatloff.bsky.social @turnaray.bsky.social: bit.ly/3OzvtIf
December 3, 2024 at 1:09 AM
Reposted by Precision Medicine Online
A case is making its way through the Colorado courts, in which the parents of twins -- a boy with Duchenne and a girl who is a DMD mutation carrier -- are suing Children's Hospital Colorado and GeneDx for alleged negligent genetic counseling and testing. My article: www.genomeweb.com/molecular-di...
Appeals Court Finds Negligence Claims Against Hospital, GeneDx Valid Under Colorado Statute
Parents are suing the defendants for negligent genetic counseling and testing that they allege precluded their ability to avoid having children with Duchenne.
drupal.prod.genomeweb.com
December 12, 2024 at 3:25 PM
Reposted by Precision Medicine Online
First-in-human results are out for three next-gen mutant PI3ka inhibitors for ER+ BC. The Scorpion and Relay compounds are headed to new trials while Loxo@Lilly is pivoting to a preclinical program due to diarrhea w/LOXO-783. #SABCS
December 11, 2024 at 1:31 PM
Reposted by Precision Medicine Online
A stem cell transplant added did not improve survival for mantle cell lymphoma patients in their first remission who had undetectable residual cells in their blood samples by a very sensitive test, a study showed. This means most patients can likely skip having a risky stem cell transplant.
Adaptive Biotechnologies' MRD Test May Allow Some Mantle Cell Lymphoma Patients to Skip Transplant
A stem cell transplant added to Rituxan did not improve survival for MRD-negative MCL patients in their first remission compared to Rituxan alone, a study showed.
www.precisionmedicineonline.com
December 11, 2024 at 4:56 PM
Reposted by Precision Medicine Online
I recently covered two new digital pathology tools-GigaPath and Ataraxis Breast-that incorporate transformer algorithms, the same type that underly GPTs. In this case a self-supervised vision transformer called DINOV2 developed at Meta. #medsky #oncsky #oncology #scicomm 🧵
GigaPath Developers Aim to Accelerate Digital Pathology for Cancer Outcomes Predictions
A foundation model built with the GigaPath algorithm outperformed other such pathology models in cancer subtyping and other prediction tasks.
www.precisionmedicineonline.com
December 6, 2024 at 3:23 PM
Reposted by Precision Medicine Online
Learned about a new dual-targeting, never-frozen (!) CAR T-cell therapy for advanced lymphoma here at #ASH24 www.precisionmedicineonline.com/precision-on...
'Fresh-In, Fresh Out' Dual-Targeted CAR T-Cell Therapy Shows Promise in Phase II DLBCL Trial
The non-cryopreserved CD19- and CD20-directed CAR T-cell therapy zamto-cel is manufactured in a closed-system device that could enable point-of-care treatment.
www.precisionmedicineonline.com
December 8, 2024 at 5:16 PM